Immunotherapy for NSCLC: Recent advances and future directions

Prof Neal Ready speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the different immunotherapies available to treat non-small-cell lung cancer (NSCLC). He describes the recent advances in this area, including the selection of patients, based on their PDL-1 expression for example. Prof Ready highlights the different types of therapy available for these patients and describes what the future looks like in this field. Sign up to ecancer for free to receive tailored email alerts for more videos like this. ecancer.org/account/register.php